Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingrehuoxuejiedu topical preparation is a Traditional Chinese Medicine (TCM) formulation developed by Xiyuan Hospital of the China Academy of Traditional Chinese Medicine. It is formulated based on the TCM therapeutic principles of clearing heat (Qingre), activating blood circulation (Huoxue), and removing toxins (Jiedu). The preparation is primarily investigated for the treatment of acute radiodermatitis, a common skin reaction in cancer patients undergoing radiotherapy. In clinical studies, such as the Phase 1 trial registered under ChiCTR-IIR-16009868, it has been evaluated for its efficacy in reducing skin inflammation and promoting the healing of radiation-induced skin injuries compared to other topical treatments like Kangfuxin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingrehuoxuejiedu topical preparation.